Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 5950Pancreatic Neoplasms 3564Carcinoma, Hepatocellular 3277Stomach Neoplasms 3058Colonic Neoplasms 2328Rectal Neoplasms 2192Esophageal Neoplasms 1801Liver Neoplasms 1248Neoplasms 1183Breast Neoplasms 1064Neoplasm Metastasis 871Carcinoma, Non-Small-Cell Lung 795Cholangiocarcinoma 748Lung Neoplasms 745Gastrointestinal Neoplasms 662Ovarian Neoplasms 632Esophageal Squamous Cell Carcinoma 585Prostatic Neoplasms 486Melanoma 458Biliary Tract Neoplasms 442Head and Neck Neoplasms 377Uterine Cervical Neoplasms 345Carcinoma, Renal Cell 331Gastrointestinal Stromal Tumors 326Adenocarcinoma Of Esophagus 315Sarcoma 304Barrett Esophagus 300Gallbladder Neoplasms 287Anus Neoplasms 284Endometrial Neoplasms 283

Interventions

isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Purpura × Gastrointestinal × Clear all
NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

SWOG Cancer Research Network

Phase 2 Completed
43 enrolled 23 charts
GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

Data powered by HemOnc (CC BY 4.0) Colophon âš¡